LAG3 and cancer: Since immune checkpoint inhibitors (ICIs) have been a prominent topic in cancer treatment, the expression of eight ICIs (LAG3, HAVCR2, CD27, TNFRSF14, CTLA4, TMIGD2, TIGIT, and PDCD1LG2) were analyzed between groups in the study.